Prollenium Unveils New Leadership Structure In a significant leadership transition aimed at fostering continued growth and innovation, Prollenium Medical Technologies (“Prollenium” or “the Company”) has announced that Ario Khoshbin, the…
RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10th RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company focused on the…
Hologic Appoints Wayde McMillan to Board of Directors Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment,…
Bayer Announces Petition Filing to U.S. Supreme Court for Review in Durnell Roundup Case On April 4, 2025, Bayer AG, through its indirect subsidiary Monsanto, officially filed a petition for…
WHO brings countries together to test collective pandemic response In a significant step toward improving global pandemic preparedness, the World Health Organization (WHO) recently led a groundbreaking two-day international simulation…
FDA Issues Complete Response Letter to Aldeyra for Reproxalap Dry Eye NDA Aldeyra Therapeutics, Inc.a biotechnology company committed to the development of innovative therapies targeting immune-mediated and metabolic diseases, announced…
Akamis Bio Doses First Patient in Phase 1b Rectal Cancer Trial of NG-350A Akamis Bio, a clinical-stage biotechnology company at the forefront of immuno-oncology innovation, announced a major milestone in…
Xaira Therapeutics Appoints Bo Wang as SVP and Head of Biomedical AI In a strategic move that underscores its deepening commitment to revolutionizing drug discovery through artificial intelligence, Xaira Therapeutics…
GoodRx Introduces New E-commerce Experience for Retail Pharmacies GoodRx, a recognized leader in medication savings platforms across the United States, has announced the introduction of a transformative e-commerce experience designed…
The HRT Club and MyMenopauseRX Team Up to Expand Menopausal Care Access Across 21 States In a major step toward improving access to affordable and patient-centered menopause healthcare, The HRT…
eClinical Solutions Highlights 2025 Shift to Risk-Based Strategies and AI in Clinical Trials eClinical Solutions LLC, a global leader in digital clinical software and services, has released the findings of…
Tecan Enhances Specialty Diagnostics Portfolio With ELISA Kit Asset Acquisition Tecan Group (SIX Swiss Exchange: TECN) has announced a strategic agreement to acquire key ELISA immunoassay assets from Cisbio Bioassays…